Integral Diagnostics Ltd. (AU:IDX) has released an update.
Invest with Confidence:
- Follow TipRanks' Top Wall Street Analysts to uncover their success rate and average return.
- Join thousands of data-driven investors – Build your Smart Portfolio for personalized insights.
Morgan Stanley has become a substantial shareholder in Integral Diagnostics Ltd, acquiring a 5.67% voting power through various entities, including securities lending agreements. This move positions Morgan Stanley as a significant player in the Australian healthcare services sector, potentially influencing the company’s strategic decisions and market performance.
For further insights into AU:IDX stock, check out TipRanks’ Stock Analysis page.